MLICM
AVNR

Metropolitan Life Insurance Company (MetLife)’s AVANIR PHARMACEUTICALS, INC CL A AVNR Stock Holding History

Metropolitan Life Insurance Company (MetLife)’s Portfolio AVNR Stock Details AVNR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-147,923
Closed -$2.51M – 2658
2014
Q4 		$2.51M Buy
147,923
+13,469
+10% +$189K 0.02% 875
2014
Q3 		$1.6M Buy
134,454
+23,915
+22% +$163K 0.01% 1027
2014
Q2 		$623K Sell
110,539
-8,248
-7% -$38K ﹤0.01% 1677
2014
Q1 		$436K Hold
118,787
– – ﹤0.01% 1908
2013
Q4 		$399K Buy
118,787
+2,284
+2% +$9.43K ﹤0.01% 1972
2013
Q3 		$494K Buy
116,503
+6,163
+6% +$29.2K ﹤0.01% 1758
2013
Q2 		$508K Buy
+110,340
New +$379K ﹤0.01% 1685

Metropolitan Life Insurance Company (MetLife)'s AVNR Position: Q1 2015 in Review

Metropolitan Life Insurance Company (MetLife) sold out of AVANIR PHARMACEUTICALS, INC CL A (AVNR) in Q1 2015, closing a stake of 147,923 shares — an estimated $2.51M sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in AVNR in Q2 2013 and held it in 7 quarters. The position peaked at $2.51M in Q4 2014. 0 funds tracked by Wall St. Rank hold AVNR as of Q1 2015.

  • Metropolitan Life Insurance Company (MetLife) reported no remaining AVANIR PHARMACEUTICALS, INC CL A position as of Q1 2015 after selling out during the quarter.
  • Metropolitan Life Insurance Company (MetLife) sold 147,923 AVANIR PHARMACEUTICALS, INC CL A shares in Q1 2015, an estimated $2.51M.
  • Metropolitan Life Insurance Company (MetLife) first reported a position in AVANIR PHARMACEUTICALS, INC CL A in Q2 2013 and held it in 7 quarters.
  • Metropolitan Life Insurance Company (MetLife)'s AVANIR PHARMACEUTICALS, INC CL A position peaked at $2.51M in Q4 2014.
  • 0 funds tracked by Wall St. Rank held AVANIR PHARMACEUTICALS, INC CL A as of Q1 2015.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q1 2015, filed 15 May 2015.